StockStory.org on MSN22h
What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be announcing earnings results tomorrow after ...
Supernus Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - SUPN
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
Supernus Pharmaceuticals Q4 2024 Earnings Preview
Supernus Pharmaceuticals (NASDAQ:SUPN) is scheduled to announce Q4 earnings results on Tuesday, February 25th, after market close. The consensus EPS Estimate is $0.52 (+2500.0% Y/Y) and the consensus ...
TD Cowen Sticks to Its Buy Rating for Centessa Pharmaceuticals (CNTA)
TD Cowen analyst Stacy Ku maintained a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report) today. The company’s shares closed last ...
Stock Index Futures Slip as Trump’s Tariffs Fuel Growth Concerns, U.S. Economic Data and Home Depot Earnings on Tap
Tech Sector Index (NDXX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...